Chronic Neuropathic Pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Having neuropathic pain. 2) Lasting neuropathic pain for at least 3 months. 3) Having a score of at least 3 points in the interview part of the DN4 Japanese version. 4) Having a score of at least 3 points on the Numerical Rating Scale measuring average pain in the last week. 5) Capable of continuing the current treatment's content as well as possible during the present trial. 6) Aged at least 18 years. 7) Having the ability to read, write, and speak Japanese. 8) Capable of obtaining written informed consent to participate in the present study based on the participants' free will. 9) Attending Shiga University of Medical Science Hospital.
Exclusion criteria
Exclusion criteria: 1) Currently receiving other psychotherapy. 2) Having experience receiving more than 4 sessions of hypnosis for pain treatment in the past. 3) Currently undergoing or planning to undergo new tests or treatments beyond the scope of usual care during the study period. 4) Cancer pain. 5) Complex regional pain syndrome type I. 6) Severe cognitive dysfunction. 7) Psychiatric problems that would preclude participation in the study now or in the past 6 months. 8) Pregnant. 9) Patients considered inappropriate to participate in the study by a doctor in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average pain intensity for the last 24 hours in the intervention and follow-up phases. | — |
Secondary
| Measure | Time frame |
|---|---|
| Maximum pain intensity for the last 24 hours. Average and maximum pain intensity for the last week. Pain interference, Psychological distress, Pain catastrophizing, Pain self-efficacy, Decentering, Readiness for pain self-management. All these outcomes will be evaluated in the intervention and follow-up phases. | — |
Countries
Japan
Contacts
Kobe University Graduate School of Human Development and Environment